Interleukin Genetics

About:

Interleukin Genetics develops genetic tests for the personalized health market.

Website: http://www.ilgenetics.com

Twitter/X: ilgenetics

Top Investors: Horizon Technology Finance, New Enterprise Associates, Bay City Capital, Alticor Corporate Enterprises, Delta Dental of Oklahoma

Description:

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

Total Funding Amount:

$64.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

1997-01-01

Contact Email:

personalized.health(AT)ilgenetics.com

Founders:

Kenneth S. Kornman

Number of Employees:

1-10

Last Funding Date:

2016-08-10

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai